191 related articles for article (PubMed ID: 31522186)
1. Life-Threatening Extrarenal Manifestations in an Infant with Atypical Hemolytic Uremic Syndrome Caused by a Complement 3-Gene Mutation.
Han SR; Cho MH; Moon JS; Ha IS; Cheong HI; Kang HG
Kidney Blood Press Res; 2019; 44(5):1300-1305. PubMed ID: 31522186
[TBL] [Abstract][Full Text] [Related]
2. Seizure as the Presenting Symptom for Atypical Hemolytic Uremic Syndrome.
Chan S; Weinstein AR
J Emerg Med; 2019 Apr; 56(4):441-443. PubMed ID: 30826084
[TBL] [Abstract][Full Text] [Related]
3. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
Besbas N; Gulhan B; Karpman D; Topaloglu R; Duzova A; Korkmaz E; Ozaltin F
Pediatr Nephrol; 2013 Jan; 28(1):155-8. PubMed ID: 22956028
[TBL] [Abstract][Full Text] [Related]
4. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children.
Fidan K; Göknar N; Gülhan B; Melek E; Yıldırım ZY; Baskın E; Hayran M; Gülleroglu K; Özçakar ZB; Ozaltin F; Soylemezoglu O
Pediatr Nephrol; 2018 Aug; 33(8):1395-1403. PubMed ID: 29610995
[TBL] [Abstract][Full Text] [Related]
5. Macrovascular involvement in a child with atypical hemolytic uremic syndrome.
Ažukaitis K; Loirat C; Malina M; Adomaitienė I; Jankauskienė A
Pediatr Nephrol; 2014 Jul; 29(7):1273-7. PubMed ID: 24352218
[TBL] [Abstract][Full Text] [Related]
6. Atypical hemolytic uremic syndrome: a case report.
Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
[TBL] [Abstract][Full Text] [Related]
7. Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.
Toyoda H; Wada H; Miyata T; Amano K; Kihira K; Iwamoto S; Hirayama M; Komada Y
J Pediatr Hematol Oncol; 2016 Apr; 38(3):e137-9. PubMed ID: 26840081
[TBL] [Abstract][Full Text] [Related]
8. [Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
Okano M; Matsumoto T; Nakamori Y; Ino K; Miyazaki K; Fujieda A; Sugimoto Y; Tawara I; Yamaguchi M; Ohishi K; Miwa H; Masuya M; Wada H; Katayama N
Rinsho Ketsueki; 2018; 59(2):178-181. PubMed ID: 29515070
[TBL] [Abstract][Full Text] [Related]
9. Atypical hemolytic uremic syndrome with C3 mutation: A case report and literature review.
Liu J; Xiao J; Chen L; Peng Y
Clin Nephrol; 2021 Mar; 95(3):156-160. PubMed ID: 33210998
[TBL] [Abstract][Full Text] [Related]
10. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report.
Fontana F; Alfano G; Bardhushi E; Ligabue G; Giovanella S; Neri I; Cappelli G
Am J Case Rep; 2019 Oct; 20():1460-1465. PubMed ID: 31582717
[TBL] [Abstract][Full Text] [Related]
11. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome.
Ipe TS; Lim J; Reyes MA; Ero M; Leveque C; Lewis B; Kain J
J Clin Apher; 2017 Dec; 32(6):584-588. PubMed ID: 28455885
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
Gediz F; Payzin BK; Ecemis S; Güler N; Yilmaz AF; Topcugil F; Berdeli A
Transfus Apher Sci; 2016 Dec; 55(3):357-362. PubMed ID: 27742267
[TBL] [Abstract][Full Text] [Related]
13. aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.
Siomou E; Gkoutsias A; Serbis A; Kollios K; Chaliasos N; Frémeaux-Bacchi V
Pediatr Nephrol; 2016 Mar; 31(3):513-7. PubMed ID: 26572892
[TBL] [Abstract][Full Text] [Related]
14. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
[TBL] [Abstract][Full Text] [Related]
15. Genetics of atypical hemolytic uremic syndrome (aHUS).
Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
[TBL] [Abstract][Full Text] [Related]
16. Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure-A Rare Presentation: Diagnosis Supported by Skin Biopsy.
Kichloo A; Chugh SS; Gupta S; Pandav J; Chander P
J Investig Med High Impact Case Rep; 2019; 7():2324709619842905. PubMed ID: 31010328
[TBL] [Abstract][Full Text] [Related]
17. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
[TBL] [Abstract][Full Text] [Related]
18. An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment.
Medeni SS; Namdaroglu S; Cetintepe T; Ozlu C; Tasli F; Adibelli ZH; Bilgir O; Tatar E
Hematol Rep; 2018 Sep; 10(3):7553. PubMed ID: 30344987
[TBL] [Abstract][Full Text] [Related]
19. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
[TBL] [Abstract][Full Text] [Related]
20. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
